Skip to main content
Caplight Logo









Tilda Research

Tilda Research

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://tilda.bio/

Last Round

Series A

May 1, 2025

Total Funding Raised

$30M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Tilda Research is a healthcare technology company that provides AI-powered services and automation to streamline clinical trials for sponsors and contract research organizations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Workflow Automation, NLP & Conversational AI, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial automationAI agentsagentic AIclinical research softwareelectronic data captureEDCclinical trial managementelectronic trial master fileeTMFworkflow automationAI teammateclinical operationsAI for pharmaSaaSregulatory compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tilda Research Comparables

Compare Tilda Research with similar companies based on industry and business-model similarity.

Tilda Research comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Florence Healthcare
81%
Vial
79%
Clinion
79%

Tilda Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2025
SeedFeb 1, 2021

Key People

Founding team and executive leadership

Ram Yalamanchili

Founder CEO

Founding Team

Tilda Research Investors

Notable investors and investment history

Tilda Research investors
InvestorRounds
Bossa InvestSeed
FloodgateSeries A, Seed
F4 FundSeries A
Optum VenturesSeed, Series A
Storm VenturesSeed
Y CombinatorSeries A, Seed
8VCSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 64, 96% of headcount.

  • Jul 13, 2026

    Open roles increased to 25, representing 37% of headcount.

Tilda Research Filings

Explore SEC and related filing metadata, where available.

Tilda Research filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tilda Research's valuation, stock price, and market status.

Is Tilda Research a public or private company?

Tilda Research is a private company.

What is the current stock price of Tilda Research?

Tilda Research is a private company with no public stock price. No recent secondary market data is available.

How much is Tilda Research worth (valuation)?

Valuation information for Tilda Research is not publicly available.

Can I buy Tilda Research stock?

Tilda Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tilda Research's last funding round?

Tilda Research's most recent funding round was Series A on May 1, 2025.

Who are the main investors in Tilda Research?

Key investors in Tilda Research include Optum Ventures, 8VC.

Will Tilda Research IPO soon?

No public IPO plans have been announced for Tilda Research.

How can I track Tilda Research secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tilda Research's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range60
Year Founded2017
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?